The scabicide effect of moxidectin in vitro and in experimental animals: Parasitological, histopathological and immunological evaluation
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Experimental Parasitology
- Vol. 217, 107961
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Excretion of Moxidectin into Breast Milk and Pharmacokinetics in Healthy Lactating WomenAntimicrobial Agents and Chemotherapy, 2011
- Moxidectin Efficacy in a Goat Herd with Chronic and Generalized Sarcoptic MangeVeterinary Medicine International, 2011
- Moxidectin: a review of chemistry, pharmacokinetics and use in horsesParasites & Vectors, 2009
- Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogsBiopharmaceutics & Drug Disposition, 2007
- The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in HumansThe Journal of Clinical Pharmacology, 2003
- Immunohistochemical Analysis of Lyme Disease in the Skin of Naive and Infection-Immune Rabbits following ChallengeInfection and Immunity, 2001
- A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies☆, ☆☆Journal of the American Academy of Dermatology, 2000
- Scabietic nodules: a dermatopathologic and immunofluorescent studyJournal of Cutaneous Pathology, 1992
- Comparison of Crotamiton 10% Cream (Eurax) and Permethrin 5% Cream (Elimite) for the Treatment of Scabies in ChildrenPediatric Dermatology, 1990